This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pal, T. Articles by Foulkes, W. D. Search for Related Content PubMed PubMed Citation Articles by Pal, T. Articles by Foulkes, W. D.

Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based Study

Center for Research in Women’s Health, Sunnybrook and Women’s College Health Sciences Center (T.P., S.B., S.A.N.), Toronto, Ontario, Canada M5G 1N8; Unit of Genetic Epidemiology, International Agency for Research on Cancer (F.D.V., H.R., D.E.G.), 69008 Lyon, France; Division of Medical Genetics, Department of Medicine, Montréal General Hospital and Cancer Prevention Research Unit, Sir Mortimer B. Davis-Jewish General Hospital, McGill University (P.O.C., K.S., T.K.), Montréal, Québec, Canada H3G 1A4; Department of Radiation Oncology, Princess Margaret Hospital, University Health Network (R.T., J.B.), Toronto, Ontario, Canada M5G 2M9; and Program in Cancer Genetics, Departments of Oncology and Human Genetics (W.D.F.), McGill University, Montréal, Québec, Canada H2W 1S6

Address all correspondence and requests for reprints to: W. D. Foulkes, M.B., Ph.D., Division of Medical Genetics, Montréal General Hospital/Room L10-120, 1650 Cedar Avenue, Montréal, Québec, Canada H3G 1A4. E-mail: william.foulkes{at}mcgill.ca

Abstract

The genetic basis for nonmedullary forms of thyroid cancer (NMTC) is less well established than that of medullary thyroid cancer. However, epidemiological and family studies suggest that a proportion of NMTC may be due to inherited predisposition. To estimate the familial risk of thyroid cancer, we conducted a hospital-based case-control study at the Princess Margaret Hospital in Toronto, Ontario, Canada, and at 2 university hospitals in Montréal, Québec, Canada. We obtained pedigrees from 339 unselected patients diagnosed with NMTC and from 319 unaffected ethnically matched controls. Family histories of cancer were obtained from the cases and controls for 3292 first degree relatives of cases and controls. Seventeen cases (5.0%) and 2 controls (0.6%) reported at least one first degree relative with thyroid cancer.

In relatives of patients with thyroid cancer, the incidence of any type of cancer (including NMTC) was 38% higher than in relatives of controls (incidence rate ratio, 1.4; 95% confidence interval, 1.1–1.7). The relative risk for thyroid cancer was 10-fold higher in relatives of cancer patients than in controls (incidence rate ratio, 10.3; 95% confidence interval, 2.2–47.6).

Our findings suggest that hereditary or other familial factors are important in a small proportion of NMTC. Molecular studies are needed to determine the genetic basis of cancer susceptibility in these families.

This article has been cited by other articles:

				K. Hemminki, C. Eng, and B. Chen Familial Risks for Nonmedullary Thyroid Cancer J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5747 - 5753. [Abstract] [Full Text] [PDF]

				J D McKay, D Thompson, F Lesueur, K Stankov, A Pastore, C Watfah, S Strolz, G Riccabona, R Moncayo, G Romeo, et al. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer J. Med. Genet., June 1, 2004; 41(6): 407 - 412. [Abstract] [Full Text] [PDF]

				C. D. Malchoff and D. M. Malchoff The Genetics of Hereditary Nonmedullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2455 - 2459. [Full Text] [PDF]